Press release
Peptide Based Gastrointestinal Disorders Therapeutics Market Strategies and Future Growth Factors with Competitive Analysis Report till 2022 Including Key Players (Shire plc, Ironwood Pharmaceuticals Inc., Astellas Pharma Inc., Allergan plc, Accredo Healt
The scope of FactMR’s report is to analyze the global Peptide Based Gastrointestinal Disorders Therapeutics Market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Drug manufacturers, research institutes, and raw material suppliers in the global peptide based gastrointestinal disorders therapeutics market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to peptide based gastrointestinal disorders therapeutics.
Get Free Sample Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=190
Pharmaceutical companies are increasingly collaborating with medical institutes and research centers in order to ramp up R&D pipelines of peptide drugs. This is expected to influence the growth of the global peptide based gastrointestinal disorders therapeutics market over the next couple of years. Rising prevalence of metabolic diseases and gastrointestinal disorders pertaining to the digestive system is prompting medical practitioners to utilize new therapeutics including peptides. In the near future, application of peptides is also expected to increase in other therapeutic areas as well. Moreover, technological advancement in peptide synthesis which include hybrid combination of liquid and solid synthesis and high-throughput approaches is expected to play a crucial role in development of more effective peptide based therapeutic drugs for treating gastrointestinal disorders. Such developments in the peptide therapeutics is also giving new hope to patients seeking affordable and effect therapeutic treatments. In addition, manufacturers are actively focusing on improving peptide properties, such as half-life and stability to address the various unmet medical needs. According to the latest report published by Fact.MR, the global peptide based gastrointestinal disorders therapeutics market is set to reflect a double-digit CAGR between 2017 and 2022, to surpass a valuation of US$ 600 Mn.
Peptide is a biologically, naturally or artificially constituted form of amino acid monomers. Peptides can be utilized for treating various gastrointestinal disorders that mostly effect parts of the digestive system such as the gastrointestinal tract, large intestine, small intestine, stomach, esophagus, and rectum. Peptides are considered as an effective therapeutic agent for treating gastrointestinal diseases. Owing to their impressive preclinical results, an array of new peptide based gastrointestinal disorder therapeutics are expected to enter the market soon.
In terms of revenue, North America is expected to hold the dominant share of the global peptide based gastrointestinal disorders therapeutics market in 2017 and beyond. Factors such growing patient awareness and rapid adoption of peptide based therapeutics for treating various diseases are expected to support the growth of the market in the region. During the forecast period, the market in the region is projected to surge at a robust CAGR of 13.9%.
Browse Complete Report In-Depth Here - https://www.factmr.com/report/190/peptide-based-gastrointestinal-disorders-therapeutics-market
On the basis of drugs, the linaclotide segment is expected to retain its dominant position over 2022. Currently, the segment accounts for more than two-third share of the market in terms of revenue. Towards the end of the forecast period, the linaclotide segment is estimated to reach a market valuation in excess of US$ 466 Mn.
Competition Tracking
Shire plc, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Allergan plc, Accredo Health Group, Inc., are the key market players profiled in the FactMR’s report. A majority of these companies are channelizing investment in further expansion of their product portfolio. This, in turn, is anticipated to result in introduction of more efficacious peptide based therapeutic drugs for curing gastrointestinal ailments.
Table of Contents
Global Peptide Based Gastrointestinal Disorders Therapeutics Market - Executive Summary
Global Peptide Based Gastrointestinal Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Definition
2.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Teduglutide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
Continued…………………..
Buy This Report from Here - https://www.factmr.com/checkout/190/S
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us -
FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Gastrointestinal Disorders Therapeutics Market Strategies and Future Growth Factors with Competitive Analysis Report till 2022 Including Key Players (Shire plc, Ironwood Pharmaceuticals Inc., Astellas Pharma Inc., Allergan plc, Accredo Healt here
News-ID: 1145492 • Views: …
More Releases from Fact.MR
Vitamin E Market to Exceed US$ 3.7 Billion by 2033, with 5.3% CAGR
The global vitamin E market (Vitamin-E-Markt) is predicted to grow at a 5.3% CAGR, from $2.2 billion in 2023 to $3.7 billion by 2033. Tocopherols are in high demand in the food and beverage, cosmetics, and animal feed industries due to their high antioxidant content, efficiency, and availability.
During the 2016-2020 historical period, vitamin E product sales expanded at a rate of 4%. As of 2021, the market is anticipated to…
Head Lice Treatment Formulations Market Set to Reach $712.2 Million by 2033
The global head lice treatment formulations market is expected to be valued at US$ 424.9 million in 2023, growing at a CAGR of 3.8% to US$ 712.2 million by the end of 2033.
Constantly increasing demand for natural hair care products has pushed manufacturers to introduce plant-based formulations into the lice treatment market. The side effects of chemical-based formulations are further driving the demand for plant-based products for head lice treatment.…
Apiculture Market is forecasted to reach a value of US$ 15.3 billion by 2032
The global apiculture market (Marché apicole) is valued at US$ 10.3 billion in 2022 and is expected to grow to US$ 15.3 billion by the end of 2032. Global market for apiculture products is expected to grow at a 4% CAGR until 2032.
Bee venom, royal jelly, propolis, bee bread, honey dew, beeswax, and honey are some essential components on the market that are commonly employed in the pharmaceutical and cosmetic…
Paper Trays Market Expected to Hit US$ 8900 Million by 2032 at 5.4% CAGR
With a compound annual growth rate (CAGR) of 5.4% from 2022 to 2032, the global paper trays market is expected to reach a value of about USD 8,900 million. In 2022, it was valued at USD 5,300 million.
In 2022, the market for paper trays will make up less than 2% of the total market for paper goods. Over the assessment period of 2022-2032, the worldwide paper tray market is expected…
More Releases for Peptide
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
There are two main types of products available in the customized peptide synthesis…
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected…
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,…
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future.
Click to Request a Sample:…
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market
Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug…
